Stoke Therapeutics (STOK)
(Delayed Data from NSDQ)
$13.68 USD
-1.06 (-7.19%)
Updated Jul 17, 2024 04:00 PM ET
After-Market: $13.68 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.55 |
EPS Last Quarter | -0.57 |
Last EPS Surprise | 5.00% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.30 |
Next Year | -2.81 |
EPS (TTM) | -2.41 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.67M | 3.46M | 15.31M | 10.96M |
# of Estimates | 3 | 4 | 3 | 3 |
High Estimate | 4.00M | 4.00M | 16.22M | 15.00M |
Low Estimate | 3.50M | 2.32M | 14.70M | 8.58M |
Year ago Sales | -2.48M | 3.31M | 8.78M | 15.31M |
Year over Year Growth Est. | 247.82% | 4.38% | 74.33% | -28.42% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.55 | -0.56 | -2.30 | -2.81 |
# of Estimates | 5 | 4 | 6 | 5 |
Most Recent Consensus | -0.49 | -0.54 | -2.35 | -3.43 |
High Estimate | -0.45 | -0.53 | -2.15 | -2.45 |
Low Estimate | -0.63 | -0.63 | -2.51 | -3.43 |
Year ago EPS | -0.69 | -0.55 | -2.38 | -2.30 |
Year over Year Growth Est. | 20.29% | -1.82% | 3.36% | -22.07% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.55 | -0.56 | -2.30 | -2.81 |
7 Days Ago | -0.55 | -0.56 | -2.30 | -2.81 |
30 Days Ago | -0.55 | -0.56 | -2.30 | -2.81 |
60 Days Ago | -0.55 | -0.56 | -2.31 | -2.81 |
90 Days Ago | -0.52 | -0.54 | -2.28 | -2.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.55 | -0.56 | -2.30 | -2.81 |
Zacks Consensus Estimate | -0.55 | -0.56 | -2.30 | -2.81 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.57 | -0.60 | -0.55 | -0.69 | NA |
Estimate | -0.60 | -0.62 | -0.65 | -0.65 | NA |
Difference | 0.03 | 0.02 | 0.10 | -0.04 | 0.03 |
Surprise | 5.00% | 3.23% | 15.38% | -6.15% | 4.37% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more